Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Electrophysiologic Effects of Growth Hormone Post-Myocardial Infarction.

Stamatis KV, Kontonika M, Daskalopoulos EP, Kolettis TM.

Int J Mol Sci. 2020 Jan 30;21(3). pii: E918. doi: 10.3390/ijms21030918. Review.

2.

The Beneficial Effects of UM206 on Wound Healing After Myocardial Infarction in Mice Are Lost in Follow-Up Experiments.

Daskalopoulos EP, Hermans KCM, Debets J, Strzelecka A, Leenders P, Vervoort-Peters L, Janssen BJA, Blankesteijn WM.

Front Cardiovasc Med. 2019 Sep 18;6:118. doi: 10.3389/fcvm.2019.00118. eCollection 2019.

3.

AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.

Gélinas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A, Daskalopoulos EP, Esfahani H, Dubois-Deruy E, Lauzier B, Gauthier C, Olson AK, Bouchard B, Des Rosiers C, Viollet B, Sakamoto K, Balligand JL, Vanoverschelde JL, Beauloye C, Horman S, Bertrand L.

Nat Commun. 2018 Jan 25;9(1):374. doi: 10.1038/s41467-017-02795-4.

4.

WNT Signaling in Cardiac and Vascular Disease.

Foulquier S, Daskalopoulos EP, Lluri G, Hermans KCM, Deb A, Blankesteijn WM.

Pharmacol Rev. 2018 Jan;70(1):68-141. doi: 10.1124/pr.117.013896. Review.

5.

Intermittent pacing therapy favorably modulates infarct remodeling.

Uitterdijk A, Springeling T, Hermans KCM, Merkus D, de Beer VJ, Gorsse-Bakker C, Mokelke E, Daskalopoulos EP, Wielopolski PA, Cleutjens JPM, Blankesteijn WM, Prinzen FW, van der Giessen WJ, van Geuns RM, Duncker DJ.

Basic Res Cardiol. 2017 May;112(3):28. doi: 10.1007/s00395-017-0616-3. Epub 2017 Apr 6.

6.

Prolonged intra-myocardial growth hormone administration ameliorates post-infarction electrophysiologic remodeling in rats.

Kontonika M, Barka E, Roumpi M, La Rocca V, Lekkas P, Daskalopoulos EP, Vilaeti AD, Baltogiannis GG, Vlahos AP, Agathopoulos S, Kolettis TM.

Growth Factors. 2017 Feb;35(1):1-11. doi: 10.1080/08977194.2017.1297432. Epub 2017 Mar 6.

PMID:
28264596
7.

Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart.

Van Steenbergen A, Balteau M, Ginion A, Ferté L, Battault S, Ravenstein CM, Balligand JL, Daskalopoulos EP, Gilon P, Despa F, Despa S, Vanoverschelde JL, Horman S, Koepsell H, Berry G, Hue L, Bertrand L, Beauloye C.

Sci Rep. 2017 Jan 27;7:41166. doi: 10.1038/srep41166.

8.

AMPK in Cardiovascular Diseases.

Daskalopoulos EP, Dufeys C, Beauloye C, Bertrand L, Horman S.

Exp Suppl. 2016;107:179-201. Review.

PMID:
27812981
9.

Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy.

Clouet S, Di Pietrantonio L, Daskalopoulos EP, Esfahani H, Horckmans M, Vanorlé M, Lemaire A, Balligand JL, Beauloye C, Boeynaems JM, Communi D.

J Biol Chem. 2016 Jul 22;291(30):15841-52. doi: 10.1074/jbc.M115.684118. Epub 2016 May 26.

10.

AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.

Daskalopoulos EP, Dufeys C, Bertrand L, Beauloye C, Horman S.

J Mol Cell Cardiol. 2016 Feb;91:188-200. doi: 10.1016/j.yjmcc.2016.01.001. Epub 2016 Jan 7. Review.

PMID:
26772531
11.

The Janus face of myofibroblasts in the remodeling heart.

Hermans KC, Daskalopoulos EP, Blankesteijn WM.

J Mol Cell Cardiol. 2016 Feb;91:35-41. doi: 10.1016/j.yjmcc.2015.11.017. Epub 2015 Dec 12. Review. No abstract available.

PMID:
26690324
12.

Central Sympathetic Activation and Arrhythmogenesis during Acute Myocardial Infarction: Modulating Effects of Endothelin-B Receptors.

Kolettis TM, Kontonika M, Barka E, Daskalopoulos EP, Baltogiannis GG, Tourmousoglou C, Papalois A, Kyriakides ZS.

Front Cardiovasc Med. 2015 Feb 23;2:6. doi: 10.3389/fcvm.2015.00006. eCollection 2015.

13.

UM206, a selective Frizzled antagonist, attenuates adverse remodeling after myocardial infarction in swine.

Uitterdijk A, Hermans KC, de Wijs-Meijler DP, Daskalopoulos EP, Reiss IK, Duncker DJ, Matthijs Blankesteijn W, Merkus D.

Lab Invest. 2016 Feb;96(2):168-76. doi: 10.1038/labinvest.2015.139. Epub 2015 Dec 14.

14.

Dopamine D2-Receptor Antagonists Down-Regulate CYP1A1/2 and CYP1B1 in the Rat Liver.

Harkitis P, Daskalopoulos EP, Malliou F, Lang MA, Marselos M, Fotopoulos A, Albucharali G, Konstandi M.

PLoS One. 2015 Oct 14;10(10):e0128708. doi: 10.1371/journal.pone.0128708. eCollection 2015.

15.

Attenuation of post-infarction remodeling in rats by sustained myocardial growth hormone administration.

Daskalopoulos EP, Vilaeti AD, Barka E, Mantzouratou P, Kouroupis D, Kontonika M, Tourmousoglou C, Papalois A, Pantos C, Blankesteijn WM, Agathopoulos S, Kolettis TM.

Growth Factors. 2015;33(4):250-8. doi: 10.3109/08977194.2015.1072527. Epub 2015 Aug 12.

PMID:
26290214
16.

Attenuation of post-infarction remodeling in rats by sustained myocardial growth hormone administration.

Daskalopoulos EP, Vilaeti AD, Barka E, Mantzouratou P, Kouroupis D, Kontonika M, Tourmousoglou C, Papalois A, Pantos C, Blankesteijn WM, Agathopoulos S, Kolettis TM.

Growth Factors. 2015 Aug 12:1-9. [Epub ahead of print]

PMID:
26267792
17.

CALibrating the CALumenin gene: New insights in overcoming the vascular CALcification CALamity?

Daskalopoulos EP.

J Mol Cell Cardiol. 2015 Jul;84:81-3. doi: 10.1016/j.yjmcc.2015.04.014. Epub 2015 Apr 23. No abstract available.

PMID:
25912188
18.

Diurnal rhythms of serum and plasma cytokine profiles in healthy elderly individuals assessed using membrane based multiplexed immunoassay.

Altara R, Manca M, Hermans KC, Daskalopoulos EP, Brunner-La Rocca HP, Hermans RJ, Struijker-Boudier HA, Blankesteijn MW.

J Transl Med. 2015 Apr 24;13:129. doi: 10.1186/s12967-015-0477-1.

19.

Targeting Wnt signaling to improve wound healing after myocardial infarction.

Daskalopoulos EP, Janssen BJ, Blankesteijn WM.

Methods Mol Biol. 2013;1037:355-80. doi: 10.1007/978-1-62703-505-7_21. Review.

PMID:
24029947
20.

Cardiac (myo)fibroblast: Novel strategies for its targeting following myocardial infarction.

Daskalopoulos EP, Hermans KC, Blankesteijn WM.

Curr Pharm Des. 2014;20(12):1987-2002. Review.

PMID:
23844732
21.

Targeting the Wnt/frizzled signaling pathway after myocardial infarction: a new tool in the therapeutic toolbox?

Daskalopoulos EP, Hermans KC, Janssen BJ, Matthijs Blankesteijn W.

Trends Cardiovasc Med. 2013 May;23(4):121-7. doi: 10.1016/j.tcm.2012.09.010. Epub 2012 Dec 21. Review.

PMID:
23266229
22.

Interventions in Wnt signaling as a novel therapeutic approach to improve myocardial infarct healing.

Hermans KC, Daskalopoulos EP, Blankesteijn WM.

Fibrogenesis Tissue Repair. 2012 Sep 11;5(1):16. doi: 10.1186/1755-1536-5-16.

23.

D₂-dopaminergic receptor-linked pathways: critical regulators of CYP3A, CYP2C, and CYP2D.

Daskalopoulos EP, Lang MA, Marselos M, Malliou F, Konstandi M.

Mol Pharmacol. 2012 Oct;82(4):668-78. Epub 2012 Jul 6.

PMID:
22772593
24.

Stress is a critical player in CYP3A, CYP2C, and CYP2D regulation: role of adrenergic receptor signaling pathways.

Daskalopoulos EP, Malliou F, Rentesi G, Marselos M, Lang MA, Konstandi M.

Am J Physiol Endocrinol Metab. 2012 Jul 1;303(1):E40-54. doi: 10.1152/ajpendo.00545.2011. Epub 2012 Apr 17.

25.

Myofibroblasts in the infarct area: concepts and challenges.

Daskalopoulos EP, Janssen BJ, Blankesteijn WM.

Microsc Microanal. 2012 Feb;18(1):35-49. doi: 10.1017/S143192761101227X. Epub 2012 Jan 4. Review.

PMID:
22214878

Supplemental Content

Loading ...
Support Center